State-of-the-Art Differentiation Protocols for Patient-Derived Cardiac Pacemaker Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Eleonora Torre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34090 Montpellier, France. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Pluripotent Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation Leducq, Agence Nationale de la Recherche, Lefoulon Delalande postdoctoral fellowship.
Abstract (Originalsprache)
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes raise the possibility of generating pluripotent stem cells from a wide range of human diseases. In the cardiology field, hiPSCs have been used to address the mechanistic bases of primary arrhythmias and in investigations of drug safety. These studies have been focused primarily on atrial and ventricular pathologies. Consequently, many hiPSC-based cardiac differentiation protocols have been developed to differentiate between atrial- or ventricular-like cardiomyocytes. Few protocols have successfully proposed ways to obtain hiPSC-derived cardiac pacemaker cells, despite the very limited availability of human tissues from the sinoatrial node. Providing an in vitro source of pacemaker-like cells would be of paramount importance in terms of furthering our understanding of the mechanisms underlying sinoatrial node pathophysiology and testing innovative clinical strategies against sinoatrial node dysfunction (i.e., biological pacemakers and genetic- and pharmacological- based therapy). Here, we summarize and detail the currently available protocols used to obtain patient-derived pacemaker-like cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34090 Montpellier, France.
- LabEx Ion Channels Science and Therapeutics (ICST), 06560 Valbonne, France.
- PhyMedExp, University of Montpellier, Inserm, CNRS, 371 Avenue du Doyen G. Giraud, CEDEX 5, 34295 Montpellier, France.
- Montpellier Organoid Platform, Biocampus, University of Montpellier, CNRS, INSERM, 34090 Montpellier, France.
ORCID-Profile: Eleonora Torre, Matteo E Mangoni, Alain Lacampagne, Albano C Meli, Pietro Mesirca
Förderung
- Fondation Leducq
- Agence Nationale de la Recherche
- Lefoulon Delalande postdoctoral fellowship
Zitieren
APA
Torre, E., Mangoni, M. E., Lacampagne, A., Meli, A. C., & Mesirca, P. (2024). State-of-the-Art Differentiation Protocols for Patient-Derived Cardiac Pacemaker Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063387
Vancouver
Torre E, Mangoni ME, Lacampagne A, Meli AC, Mesirca P. State-of-the-Art Differentiation Protocols for Patient-Derived Cardiac Pacemaker Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063387
BibTeX
@article{Torre2024,
author = {Torre, Eleonora and Mangoni, Matteo E and Lacampagne, Alain and Meli, Albano C and Mesirca, Pietro},
title = {State-of-the-Art Differentiation Protocols for Patient-Derived Cardiac Pacemaker Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063387}
}
EUVIMED